SV7 Impact Medicine Fund LP's Form 4/A amendment
AmendedXilio Therapeutics, Inc. (XLO) · filed Nov 3, 2021
- Accession no.
- 0000899243-21-042710
- Filed
- Nov 3, 2021, 4:20 PM ET
- Trade date
- Oct 26, 2021
- Filing delay
- 8 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Oct 28, 2021
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market purchases total $10.0M. It was filed 8 days after the trade.
This amendment replaces 0000899243-21-041838 (filed Oct 28, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| SV7 Impact Medicine Fund LPCIK 0001780602 | 10% Owner |
| SV7 (Imf) GP LLPCIK 0001889859 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionAcquired | +998,544 | – | – | 998,544 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +998,544 | – | – | 998,544 | Indirect | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +302,588 | – | – | 1,301,132 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionAcquired | +302,588 | – | – | 1,301,132 | Indirect | |
| Oct 26, 2021 | Common Stock | PPurchaseAcquired | +312,500 | $16.00 | +$5,000,000 | 1,613,632 | Direct | |
| Oct 26, 2021 | Common Stock | PPurchaseAcquired | +312,500 | $16.00 | +$5,000,000 | 1,613,632 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | Common Stock | CConversionDisposed | −998,544 | $0.00 | $0 | 0 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −998,544 | $0.00 | $0 | 0 | Indirect | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −302,588 | $0.00 | $0 | 0 | Direct | |
| Oct 26, 2021 | Common Stock | CConversionDisposed | −302,588 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.